Drugs / ABT-102
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00854659 Comparator | Mar → Jun 2009 | — | Abbott | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABT-102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00854659 ↗ |
| Action | Inhibit | “The capsaicin receptor (TRPV1) antagonist ABT-102 demonstrates efficacy in multiple preclinical pain models.” PMID 21377273 ↗ Mar 2011 |
| Modality | Small molecule | — CHEMBL398338 ↗ |
| Target | TRPV1 | “The capsaicin receptor (TRPV1) antagonist ABT-102 demonstrates efficacy in multiple preclinical pain models.” PMID 21377273 ↗ Mar 2011 |